Deborah Charych's most recent trade in Skye Bioscience Inc was a trade of 75,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 31, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Skye Bioscience Inc | Deborah Charych | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Deborah Charych | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2026 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Charych Deborah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Skye Bioscience Inc | Deborah Charych | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Oct 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) |